RESUMO
STUDY OBJECTIVES: Dexmedetomidine is used clinically to induce states of sedation that have been described as homologous to nonrapid eye movement (NREM) sleep. A better understanding of the similarities and differences between NREM sleep and dexmedetomidine-induced sedation is essential for efforts to clarify the relationship between these two states. This study tested the hypothesis that dexmedetomidine-induced sedation is homologous to sleep. DESIGN: This study used between-groups and within-groups designs. SETTING: University of Michigan. PARTICIPANTS: Adult male Sprague Dawley rats (n = 40). INTERVENTIONS: Independent variables were administration of dexmedetomidine and saline or Ringer's solution (control). Dependent variables included time spent in states of wakefulness, sleep, and sedation, electroencephalographic (EEG) power, adenosine levels in the substantia innominata (SI), and activation of pCREB and c-Fos in sleep related forebrain regions. MEASUREMENTS AND RESULTS: Dexmedetomidine significantly decreased time spent in wakefulness (-49%), increased duration of sedation (1995%), increased EEG delta power (546%), and eliminated the rapid eye movement (REM) phase of sleep for 16 h. Sedation was followed by a rebound increase in NREM and REM sleep. Systemically administered dexmedetomidine significantly decreased (-39%) SI adenosine levels. Dialysis delivery of dexmedetomidine into SI did not decrease adenosine level. Systemic delivery of dexmedetomidine did not alter c-Fos or pCREB expression in the horizontal diagonal band, or ventrolateral, median, and medial preoptic areas of the hypothalamus. CONCLUSIONS: Dexmedetomidine significantly altered normal sleep phenotypes, and the dexmedetomidine-induced state did not compensate for sleep need. Thus, in the Sprague Dawley rat, dexmedetomidine-induced sedation is characterized by behavioral, electrographic, and immunohistochemical phenotypes that are distinctly different from similar measures obtained during sleep.
Assuntos
Dexmedetomidina/farmacologia , Hipnóticos e Sedativos/farmacologia , Fenótipo , Sono/fisiologia , Adenosina/metabolismo , Animais , Prosencéfalo Basal/efeitos dos fármacos , Prosencéfalo Basal/metabolismo , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico/metabolismo , Dexmedetomidina/administração & dosagem , Diálise , Eletroencefalografia , Regulação da Expressão Gênica/efeitos dos fármacos , Hipotálamo/efeitos dos fármacos , Hipotálamo/metabolismo , Masculino , Proteínas Proto-Oncogênicas c-fos/metabolismo , Ratos , Ratos Sprague-Dawley , Sono/efeitos dos fármacos , Sono REM/efeitos dos fármacos , Sono REM/fisiologia , Substância Inominada/efeitos dos fármacos , Substância Inominada/metabolismo , Fatores de Tempo , Vigília/efeitos dos fármacos , Vigília/fisiologiaRESUMO
Orexin/hypocretin neurons of the lateral hypothalamus/perifornical area project to a diverse array of brain regions and are responsive to a variety of psychostimulant drugs. It has been shown that orexin neurons are activated by systemic nicotine administration suggesting a possible orexinergic contribution to the effects of this drug on arousal and cognitive function. The basal forebrain and paraventricular nucleus of the dorsal thalamus (PVT) both receive orexin inputs and have been implicated in arousal, attention and psychostimulant drug responses. However, it is unknown whether orexin inputs to these areas are activated by psychostimulant drugs such as nicotine. Here, we infused the retrograde tract tracer cholera toxin B subunit (CTb) into either the basal forebrain or PVT of adult male rats. Seven to 10 days later, animals received an acute systemic administration of (-) nicotine hydrogen tartrate or vehicle and were euthanized 2h later. Triple-label immunohistochemistry/immunofluorescence was used to detect Fos expression in retrogradely-labeled orexin neurons. Nicotine increased Fos expression in orexin neurons projecting to both basal forebrain and PVT. The relative activation in lateral and medial banks of retrogradely-labeled orexin neurons was similar following basal forebrain CTb deposits, but was more pronounced in the medial bank following PVT deposits of CTb. Our findings suggest that orexin inputs to the basal forebrain and PVT may contribute to nicotine effects on arousal and cognition and provide further support for the existence of functional heterogeneity across the medial-lateral distribution of orexin neurons.
Assuntos
Vias Eferentes/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Núcleos da Linha Média do Tálamo/metabolismo , Neurônios/metabolismo , Nicotina/farmacologia , Animais , Toxina da Cólera/administração & dosagem , Toxina da Cólera/metabolismo , Vias Eferentes/citologia , Vias Eferentes/efeitos dos fármacos , Imunofluorescência/métodos , Globo Pálido/citologia , Globo Pálido/efeitos dos fármacos , Globo Pálido/metabolismo , Imuno-Histoquímica/métodos , Injeções Intraperitoneais , Peptídeos e Proteínas de Sinalização Intracelular/administração & dosagem , Peptídeos e Proteínas de Sinalização Intracelular/efeitos dos fármacos , Masculino , Núcleos da Linha Média do Tálamo/citologia , Núcleos da Linha Média do Tálamo/efeitos dos fármacos , Neurônios/citologia , Neurônios/efeitos dos fármacos , Neuropeptídeos/administração & dosagem , Neuropeptídeos/metabolismo , Neurotransmissores/administração & dosagem , Neurotransmissores/metabolismo , Neurotransmissores/farmacologia , Nicotina/administração & dosagem , Orexinas , Proteínas Proto-Oncogênicas c-fos/biossíntese , Proteínas Proto-Oncogênicas c-fos/metabolismo , Ratos , Ratos Sprague-Dawley , Substância Inominada/citologia , Substância Inominada/efeitos dos fármacos , Substância Inominada/metabolismo , Tálamo/citologia , Tálamo/efeitos dos fármacos , Tálamo/metabolismoRESUMO
Pharmacological studies have suggested that the m2 muscarinic receptor functions as an autoreceptor in the cholinergic axons which innervate the cerebral cortex and striatum. To test this hypothesis in the macaque monkey, we used a subtype-specific antibody to the m2 muscarinic receptor. Immunoreactive cells were well visualized in the nucleus basalis, where some of these cells displayed dense m2 immunoreactivity, while others were lightly labeled. This heterogeneity of labeling intensity was not based on peculiarities of the methodology, because cholinergic cells of the striatum expressed uniformly dense m2 immunoreactivity. Concurrent labeling with choline acetyltransferase immunoreactivity proved that most of the heavily m2-labeled cells in the nucleus basalis were also choline acetyl-transferase positive. The findings demonstrate that at least 10-25% of the cholinergic neurons in the nucleus basalis of the monkey are densely m2 immunoreactive. In the striatum, concurrent labeling demonstrated that the majority, if not all, choline acetyltransferase-positive cells also contained m2 immunoreactivity. In addition, these experiments identified a population of smaller striatal cells which were m2 immunoreactive and choline acetyltransferase negative. Consecutive labeling with m2 immunoreactivity and NADPH-diaphorase histochemistry demonstrated that many of these m2-immunoreactive non-cholinergic neurons belonged to the population of nitric oxide-synthesizing medium aspiny neurons. The findings indicate that the m2 muscarinic receptor may be expressed at high levels in only a subset of cholinergic basal forebrain neurons. In contrast, m2 receptors appear to be expressed by all cholinergic cells of the striatum.
Assuntos
Colina O-Acetiltransferase/metabolismo , Corpo Estriado/metabolismo , Neurônios/metabolismo , Prosencéfalo/metabolismo , Receptores Muscarínicos/metabolismo , Animais , Corpo Estriado/citologia , Lobo Frontal/citologia , Lobo Frontal/metabolismo , Imuno-Histoquímica , Macaca nemestrina , Neurônios/citologia , Prosencéfalo/citologia , Septo Pelúcido/citologia , Septo Pelúcido/metabolismo , Substância Inominada/citologia , Substância Inominada/metabolismoRESUMO
We investigated the effects of egg phosphatidylcholine (PC) combined with vitamin B12 on memory in the Morris water maze task, and on choline and acetylcholine (ACh) concentrations in the brain of rats. Animals with nucleus basalis Magnocellularis (NBM) lesion received intragastric administration of egg PC or vitamin B12, or both for 18 days. Memory acquisition and retention were remarkably impaired in NBM lesioned rats compared with in sham-operated control. NBM lesioned group had lower choline and ACh concentrations than control group in the frontal cortex. High dose of egg PC alone significantly increased choline concentration, but did not change ACh concentration in the frontal cortex. High dose of vitamin B12 alone did not change choline and ACh concentrations in the brain. Either egg PC or vitamin B12 did not improve memory acquisition and retention. However, low dose of egg PC combined with vitamin B12 significantly increased ACh concentration and improved memory acquisition and retention in the NBM lesioned rats. We concluded that egg PC combined with vitamin B12 improved the memory impairment of NBM lesioned rats through the action on the cholinergic neurons.
Assuntos
Transtornos da Memória/tratamento farmacológico , Fosfatidilcolinas/uso terapêutico , Substância Inominada/patologia , Vitamina B 12/uso terapêutico , Acetilcolina/metabolismo , Animais , Comportamento Animal/efeitos dos fármacos , Colina/metabolismo , Ovos , Masculino , Fosfatidilcolinas/administração & dosagem , Fosfatidilcolinas/farmacologia , Ratos , Ratos Wistar , Substância Inominada/metabolismo , Vitamina B 12/administração & dosagem , Vitamina B 12/farmacologiaRESUMO
The phenylethanolamine-N-methyltransferase (PNMT)-containing neurons in the rostral ventrolateral medulla (RVLM) (the C1 adrenergic group) have been implicated in the generation of the tonic sympathetic nerve activity. Using a double-labeling immunohistofluorescence technique, we found that 34.6 +/- 11.4% (mean +/- S.D.) of PNMT immunoreactive neurons in the RVLM were immunoreactive for Calbindin D-28k (CaBP), a Vitamin D-dependent calcium binding protein. Since CaBP is probably involved in regulating intracellular calcium concentrations in cells that are metabolically or electrically very active, our results suggest that at least some C1 adrenergic neurons (those containing calbindin) may have calcium mediated high metabolic or electrophysiologic activity that is associated with generating tonic nerve function. The RVLM has wide connections with many different nuclei in the brain which are known to contain clusters of neurons that express immunoreactivity to CaBP. In order to determine whether CaBP could be used as a molecular marker for projection neurons to the RVLM or to identify a subpopulation of projection neurons containing CaBP, we sought to determine the relationships between CaBP and the neurons that project to RVLM. Following injections of the retrograde tracer FluoroGold (FG) into the rat RVLM, sections containing retrogradely labeled neurons in (1) the nucleus tractus solitarii (NTS), (2) the contralateral RVLM, (3) the area postrema, (4) the mesencephalic central gray (mCG), (5) the lateral hypothalamus (LH), (6) the substantia innominata (SI), and (7) the paraventricular hypothalamic nucleus (PV) were tested for CaBP immunoreactivity. Although many retrogradely labeled neurons were found amidst many CaBP immunoreactive neurons in each of these nuclei, only a subpopulation of the retrogradely labeled neurons expressed CaBP immunoreactivity. The NTS demonstrated the higher proportion of double-labeled cells (mean 31.5 +/- 4.3%), whereas the lower proportion corresponded to the contralateral RVLM (mean 9.6 +/- 3.2%). On the other hand, both the retrogradely labeled neurons and the CaBP immunoreactive neurons in each of these nuclei were often found in regions containing a great number of adrenergic axons (i.e. immunoreactive for PNMT). Our results suggest that: (1) Two types of adrenergic RVLM neurons could be found, those containing CaBP and those lacking this calcium binding protein. (2) CaBP is not a common marker for the afferent neurons to the RVLM, but rather is found in selective subsets of them. (3) Both the non-CaBP projection neurons and the CaBP immunoreactive neurons in these nuclei may be innervated by adrenergic fibers.
Assuntos
Bulbo/metabolismo , Neurônios Aferentes/metabolismo , Neurônios Aferentes/fisiologia , Proteína G de Ligação ao Cálcio S100/metabolismo , Estilbamidinas , Transmissão Sináptica , Animais , Calbindinas , Eletrofisiologia , Imunofluorescência , Corantes Fluorescentes , Hipotálamo/citologia , Hipotálamo/metabolismo , Masculino , Bulbo/citologia , Peso Molecular , Neurônios/fisiologia , Substância Cinzenta Periaquedutal/citologia , Substância Cinzenta Periaquedutal/metabolismo , Ratos , Ratos Sprague-Dawley , Proteína G de Ligação ao Cálcio S100/química , Substância Inominada/citologia , Substância Inominada/metabolismo , Sistema Nervoso Simpático/citologia , Sistema Nervoso Simpático/metabolismoRESUMO
Choline acetyltransferase and acetylcholinesterase activities as well as serotonin and imipramine binding were determined in the hypothalamus, nucleus basalis of Meynert, and frontal and temporal poles of subjects with Pick's disease. Choline acetyltransferase activity was decreased in the hypothalamus and nucleus basalis of Meynert, and acetylcholinesterase activity was decreased in the nucleus basalis of Meynert only. Serotonin binding was decreased in all sites but the nucleus basalis of Meynert, and imipramine binding was altered only in the frontal pole. Comparison with previous reports of Alzheimer's disease indicates that with respect to these synaptic markers, Alzheimer's disease and Pick's disease are not similar.
Assuntos
Acetilcolinesterase/metabolismo , Encéfalo/metabolismo , Colina O-Acetiltransferase/metabolismo , Demência/metabolismo , Imipramina/metabolismo , Serotonina/metabolismo , Sinapses/metabolismo , Idoso , Feminino , Lobo Frontal/metabolismo , Humanos , Hipotálamo/metabolismo , Masculino , Substância Inominada/metabolismo , Lobo Temporal/metabolismoRESUMO
The basal forebrain magnocellular complex of primates is defined by the presence of large, hyperchromic, usually cholinergic neurons in the nucleus basalis of Meynert and nucleus of the diagonal band of Broca. Because there is growing evidence for noncholinergic neuronal elements in the basal forebrain complex, five neuropeptides and the enzyme choline acetyltransferase were studied immunocytochemically in this region of rhesus monkeys. Galaninlike immunoreactivity coexists with choline-acetyl-transferase-like immunoreactivity in most large neurons and in some smaller neurons of the primate nucleus basalis and nucleus of the diagnonal band. Four other peptides show immunoreactivity in more limited regions of the basal forebrain complex, usually in separate smaller, noncholinergic neurons. Numerous small, somatostatinlike-immunoreactive neurons occupy primarily anterior and intermediate segments of the nucleus basalis, especially laterally and ventrally. Somewhat fewer, small neuropeptide Y-like-immunoreactive somata are found in the same regions. Neurons that show neurotensinlike immunoreactivity are slightly larger than cells that contain immunoreactivity for somatostatin or neuropeptide Y, but these neurons also occur mainly in anterior and intermediate parts of the nucleus basalis. Overall, the usually small, leucine-enkephalin-like-immunoreactive neurons are infrequent in the basal forebrain complex and are most abundant in the rostral intermediate nucleus basalis. Thus, neurons that appear to contain somatostatin, neuropeptide Y, neurotensin, or enkephalin mingle with cholinergic/galaninergic neurons only in some subdivisions of the nucleus basalis/nucleus of the diagonal band, and their distributions suggest that some of these small neurons could be associated with structures that overlap with cholinergic neurons of the labyrinthine basal forebrain magnocellular complex. We also have found light microscopic evidence for innervation of basal forebrain cholinergic neurons by boutons that contain galanin-, somatostatin-, neuropeptide Y-, neurotensin-, or enkephalinlike immunoreactivity. The origins and functions of these putative synapses remain to be determined.
Assuntos
Gânglios da Base/metabolismo , Lobo Frontal/metabolismo , Macaca mulatta/metabolismo , Macaca/metabolismo , Neuropeptídeos/metabolismo , Substância Inominada/metabolismo , Animais , Mapeamento Encefálico , Colina O-Acetiltransferase/metabolismo , Encefalinas/metabolismo , Lobo Frontal/citologia , Galanina , Imuno-Histoquímica , Macaca mulatta/anatomia & histologia , Masculino , Neuropeptídeo Y/metabolismo , Peptídeos/metabolismo , Somatostatina/metabolismo , Substância Inominada/citologiaRESUMO
The main objective of the present study was to determine whether cholinergic markers (choline acetyltransferase activity and nicotinic and muscarinic receptors) are altered in Alzheimer's disease. Choline acetyltransferase activity in Alzheimer's brains was markedly reduced in various cortical areas, in the hippocampus, and in the nucleus basalis of Meynert. The maximal density of nicotinic sites, measured using the novel nicotinic radioligand N-[3H]methylcarbamylcholine, was decreased in cortical areas and hippocampus but not in subcortical regions. M1 muscarinic cholinergic receptor sites were assessed using [3H]pirenzepine as a selective ligand; [3H]pirenzepine binding parameters were not altered in most cortical and subcortical structures, although the density of sites was modestly increased in the hippocampus and striatum. Finally, M2-like muscarinic sites were studied using [3H]-acetylcholine, under muscarinic conditions. In contrast to M1 muscarinic sites, the maximal density of M2-like muscarinic sites was markedly reduced in all cortical areas and hippocampus but was not altered in subcortical structures. These findings reveal an apparently selective alteration in the densities of putative nicotinic and muscarinic M2, but not M1, receptor sites in cortical areas and in the hippocampus in Alzheimer's disease.
Assuntos
Doença de Alzheimer/metabolismo , Encéfalo/metabolismo , Carbacol/análogos & derivados , Colina O-Acetiltransferase/metabolismo , Receptores Colinérgicos/metabolismo , Acetilcolina/metabolismo , Idoso , Idoso de 80 Anos ou mais , Córtex Cerebral/metabolismo , Colina/análogos & derivados , Colina/metabolismo , Corpo Estriado/metabolismo , Feminino , Globo Pálido/metabolismo , Hipocampo/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Pirenzepina/metabolismo , Receptores Muscarínicos/metabolismo , Receptores Nicotínicos/metabolismo , Substância Inominada/metabolismo , Tálamo/metabolismoRESUMO
Nerve growth factor (NGF) receptors were visualized in the basal human forebrain using an immunohistochemical procedure with a monoclonal antibody previously shown to recognize human melanoma cell NGF receptors. The receptors were found to be exclusively located in the medical septal nucleus, the diagonal band of Broca, and the nucleus basalis. This location coincided with that of cell bodies of ascending cholinergic neurons of the basal forebrain. In addition, NGF receptor-positive cells were costained for acetylcholinesterase. These findings indicate that cholinergic neurons of the basal forebrain but none of the other neurons located in this area express receptors for NGF. Results suggest that NGF acts as a trophic factor for cholinergic neurons in the human brain in a similar way as has been established in recent years for the rat brain.